Temodal Melanoma Symptom Correlation Analysis Suggested By Cmte.
Executive Summary
Correlation of symptom improvements to tumor response rate would be one way to demonstrate efficacy of Schering-Plough's Temodal in patients with malignant melanoma, members of FDA's Oncologic Drugs Advisory Committee suggested March 23.